Eide Per Kristian, Eidsvaag Vigdis Andersen, Hansson Hans-Arne
Department of Neurosurgery, Oslo University Hospital - Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Neurosurgery, Oslo University Hospital - Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
J Neurol Sci. 2014 Aug 15;343(1-2):132-7. doi: 10.1016/j.jns.2014.05.054. Epub 2014 Jun 2.
Antisecretory factor (AF) and derivates thereof counteract brain edema and inflammation, and normalize ICP dynamics. The aim of the present study was to assess whether AF normalized the abnormal ICP waves, indicative of impaired intracranial compliance, seen in patients with idiopathic normal pressure hydrocephalus (iNPH) and idiopathic intracranial hypertension (IIH). The hypothesis was that brain swelling contributes to the abnormal ICP waves.
The study enrolled patients undergoing diagnostic ICP wave monitoring for either iNPH or IIH. The ICP waves and ICP were recorded continuously before and after oral administration of Salovum® (0.5 g/kg body weight/day divided by three doses), a freeze-dried egg yolk enriched in AF activity. Mean ICP wave amplitude (MWA), mean ICP wave rise time coefficient (MWRTC), and mean ICP were compared before and after Salovum® administration.
A total of 10 iNPH patients and 8 IIH patients were included. No significant changes in the ICP wave indices or ICP were seen after Salovum® administration. Neither any significant time-dependent effect was observed.
The lack of effect of Salovum® on ICP wave indices and ICP in iNPH and IIH may provide indirect evidence that brain swelling does not play a crucial role in the ICP wave indices or ICP of these conditions.
抗分泌因子(AF)及其衍生物可对抗脑水肿和炎症,并使颅内压(ICP)动态恢复正常。本研究的目的是评估AF是否能使特发性正常压力脑积水(iNPH)和特发性颅内高压(IIH)患者出现的异常ICP波恢复正常,这些异常波表明颅内顺应性受损。假设是脑肿胀导致了异常ICP波。
该研究纳入了因iNPH或IIH接受诊断性ICP波监测的患者。在口服富含AF活性的冻干蛋黄Salovum®(0.5 g/kg体重/天,分三次服用)之前和之后,连续记录ICP波和ICP。比较Salovum®给药前后的平均ICP波振幅(MWA)、平均ICP波上升时间系数(MWRTC)和平均ICP。
共纳入10例iNPH患者和8例IIH患者。服用Salovum®后,ICP波指标或ICP均无显著变化。也未观察到任何显著的时间依赖性效应。
Salovum®对iNPH和IIH患者的ICP波指标及ICP缺乏作用,这可能间接证明脑肿胀在这些疾病的ICP波指标或ICP中不起关键作用。